TATSIS OURANIA (SVP, CRO) sold 3.1% of their position (1.50K shares) of VERTEX PHARMACEUTICALS INC / MA on the open market
Open‑market sale worth $750.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/18/2026ACC: 0000875320-26-000076
Officer· SVP, CRO
Since Oct 2019
-5.30K
Net shares
Net seller
$2.61M
Total sold
1
Open market trades
0B · 1S
2
Total transactions
5.30K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−3.80K
Price / share
$487.76
Trade value
$1.86M
% of position
7.4%
2/13/2026
51.44K→47.63K
Common Stock
Direct
Shares
−1.50K
Price / share
$499.99
Trade value
$749.99K
% of position
3.1%
2/13/2026
47.63K→46.13K
Total
Net shares
−5.30K
Net value
-$2.61M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/13/2026 | F · Tax Withholding | −3.80K | $487.76 | $1.86M | 7.4% | 51.44K | 47.63K |
| Common Stock Direct | 2/13/2026 | S · Sale | −1.50K | $499.99 | $749.99K | 3.1% | 47.63K | 46.13K |
| Total | −5.30K | -$2.61M | ||||||
Derivative Transactions0
No derivative transactions reported